LGMLJun 16, 2014

Personalized Medical Treatments Using Novel Reinforcement Learning Algorithms

arXiv:1406.3922v24 citations
Originality Incremental advance
AI Analysis

This work addresses the challenge of personalized medical treatments for patients with chronic conditions like depression, offering a method that handles censored data, though it appears incremental as it builds on existing Q-learning techniques.

The authors tackled the problem of finding optimal personalized treatment policies for patients with variable responses by developing a novel Q-learning algorithm that adjusts for censored data and varying stages, demonstrating its effectiveness through simulations and real data analysis, showing it outperforms state-of-the-art clinical decision support systems.

In both the fields of computer science and medicine there is very strong interest in developing personalized treatment policies for patients who have variable responses to treatments. In particular, I aim to find an optimal personalized treatment policy which is a non-deterministic function of the patient specific covariate data that maximizes the expected survival time or clinical outcome. I developed an algorithmic framework to solve multistage decision problem with a varying number of stages that are subject to censoring in which the "rewards" are expected survival times. In specific, I developed a novel Q-learning algorithm that dynamically adjusts for these parameters. Furthermore, I found finite upper bounds on the generalized error of the treatment paths constructed by this algorithm. I have also shown that when the optimal Q-function is an element of the approximation space, the anticipated survival times for the treatment regime constructed by the algorithm will converge to the optimal treatment path. I demonstrated the performance of the proposed algorithmic framework via simulation studies and through the analysis of chronic depression data and a hypothetical clinical trial. The censored Q-learning algorithm I developed is more effective than the state of the art clinical decision support systems and is able to operate in environments when many covariate parameters may be unobtainable or censored.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes